-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

705.O2.6 705. Cellular Immunotherapies: Late Phase and Commercially Available Therapies: Cellular Therapy for Multiple Myeloma, B-cell Acute Lymphoblastic Leukemia and B Cell Lymphomas: Clinical Trial and Real World Evidence

Symposia: Cellular Immunotherapies: Late Phase and Commercially Available Therapies Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Lymphoid Leukemias, ALL, Lymphomas, Clinical Research, B Cell lymphoma, Plasma Cell Disorders, Diseases, real-world evidence, registries, Lymphoid Malignancies
Monday, December 11, 2023: 4:30 PM-6:00 PM
Room 6CF (San Diego Convention Center)
Moderators:
Krina K. Patel, MD, MSc, The University of Texas MD Anderson Cancer Center and Larry D. Anderson Jr., MD, PhD, UT Southwestern Medical Center
Disclosures:
Patel: AbbVie; Arcellx, AstraZeneca; Bristol Myers Squibb/Celgene Corporation; Caribou Science; Cellectis; Curio Bioscience; Genentech; Janssen Pharmaceuticals, Inc.; Karyopharm; Legend Biotech; Merck & Co., Inc.; Oncopeptides; Pfizer; Precision BioSciences: Consultancy; AbbVie; Allogene Therapeutics, Inc.; Arcellx; Bristol Myers Squibb/Celgene Corporation; Cellectis; Janssen Pharmaceuticals, Inc.; Nektar Therapeutic; Poseida Therapeutics; Precision BioSciences, Inc.; and Takeda Pharmaceuticals U.S.A., Inc.: Research Funding; Takeda: Consultancy. Anderson: Janssen: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding; Celgene: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding; Bristol Myers Squibb: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding; Amgen: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees; GlaxoSmithKline: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees; AbbVie: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees; Beigene: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees; Cellectar: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees; Sanofi: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees; Prothena: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees.
This session focuses on clinical trial updates and real world data for Hematologic Malignancies including multiple myeloma, B-cell ALL and B-cell lymphomas.
4:30 PM

Surbhi Sidana, MD1, Nausheen Ahmed, MD2, Othman S Akhtar, MD3, Michael Heim, MS4*, Ruta Brazauskas, PhD5,6*, Doris K. Hansen, MD7*, Christopher Ferreri, MD8*, Ciara Louise L. Freeman, MD, PhD, MSc9, Aimaz Afrough, MD10*, Larry D. Anderson Jr., MD, PhD11, Binod Dhakal, MD, MS12*, Devender Dhanda, PhD13*, Lohith Gowda, MD14*, Hamza Hashmi, MD15*, Melanie Harrison16*, Amani Kitali, MBA, MPH, PMP13*, Sayeef Mirza, MD, MPH17, Jinalben Patel, MPH6*, Pallavi Patwardhan16*, Saad Z Usmani, MD18, Krina K. Patel, MD, MSc19, Siddhartha Ganguly, MD20 and Marcelo Pasquini, MD, MS6

1Stanford University, Stanford, CA
2University of Kansas Cancer Center, Westwood, KS
3Moffit Cancer Center, Tampa, FL
4CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
5Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee
6CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee
7H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
8The University of Texas MD Anderson Cancer Center, Houston
9Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
10UT Southwestern Medical Center, Dallas, TX
11Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
12BMT and Cellular Therapy, Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee
13Bristol Myers Squibb, Princeton, NJ
14Yale Cancer Center and Yale School of Medicine, New Haven, CT
15Medical University of South Carolina, Charleston
16Bristol Myers Squibb, Princeton
17Yale School of Medicine, New Haven
18Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
19The University of Texas MD Anderson Cancer Center, Houston, TX
20Houston Methodist Hospital and Neal Cancer Center, Houston, TX

4:45 PM

Paula Rodríguez Otero1*, Sikander Ailawadhi2, Bertrand Arnulf, MD, PhD3, Krina K. Patel, MD, MSc4, Michele Cavo, MD5*, Ajay K. Nooka, MD, MPH6, Salomon Manier, MD, PhD7, Natalie S. Callander, MD8, Luciano Costa, MD, PhD9, Ravi Vij, MD, MBA10, Nizar J Bahlis, MD11, Philippe Moreau, MD, PhD12*, Scott R. Solomon, MD13, Ingerid Weum Abrahamsen14*, Rachid Baz, MD15, Annemiek Broijl, MD, PhD16, Christine Chen, MHPE, MD, FRCPC17, Sundar Jagannath18, Noopur S. Raje19*, Christof Scheid20*, Michel Delforge21*, Reuben Benjamin22*, Thomas Pabst, MD23, Shinsuke Iida24, Jesus G. Berdeja, MD25, Anna Truppel-Hartmann, MD26*, Rashmi Bhatnagar27*, Fan Wu28*, Julia Piasecki28*, Laurie Eliason, MPH28*, Devender Dhanda, PhD28*, Jasper Felten28*, Andrea Caia28*, Mark Cook, MBChB, PhD29, Mihaela Popa-McKiver, MD, PhD28* and Sergio A. Giralt, MD, FACP30

1Clínica Universidad de Navarra, Pamplona, Spain
2Mayo Clinic, Jacksonville, FL
3Hôpital Saint-Louis, APHP, Université Paris cite, Paris, France
4MD Anderson Cancer Center, University of Texas, Houston, TX
5IRCCS Azienda Ospedaliero-Universitaria di Bologna, Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy
6Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
7CHU Lille, Université de Lille, Lille, France
8University of Wisconsin Carbone Cancer Center, Madison, WI
9University of Alabama at Birmingham, Birmingham, AL
10Division of Oncology, Washington University School of Medicine, Saint Louis, MO
11Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada
12University Hospital of Nantes, Nantes, France
13Northside Hospital Cancer Institute, Atlanta, GA
14Oslo University Hospital, Oslo, Norway
15H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
16Erasmus MC Cancer Institute, Rotterdam, Netherlands
17Princess Margaret Hospital, Toronto, ON, Canada
18Mount Sinai Medical Center, New York, NY
19Massachusetts General Hospital, Boston, MA
20University of Cologne, Cologne, Germany
21Universitaire Ziekenhuizen Leuven, Leuven, Belgium
22Kings College Hospital, London, United Kingdom
23Bern University Hospital, Bern, Switzerland
24Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
25Sarah Cannon Research Institute, Nashville, TN
262seventy bio, Cambridge, MA
27Syneos Health, Haryana, India
28Bristol Myers Squibb, Princeton, NJ
29Bristol Myers Squibb, Boudry, Switzerland
30Weill Cornell Medical College, Memorial Sloan Kettering Cancer Center, New York, NY

5:00 PM

Evandro Bezerra, MD1, Taha Itani, PhD, MPH2*, Kistada Wudhikarn, MD3*, Miguel-Angel Perales, MD4, Yang Yang, MD5, Usama Gergis, MD, MBA5*, Ahmed Aribi, MD6*, LaQuisa C. Hill, MD7*, Nitin Jain, MD8, Jessica T. Leonard, MD9, Forat Lutfi, MD10, Soyoung Kim, PhD11*, Matthew Bye, MPH12*, Hai-Lin Wang, MPH2*, Tsveta Hadjivassileva, PhD2*, Liana Nikolaenko, MD2*, Ioana Kloos, MD2*, Amina Abdeldaim, MD, MPH2*, David Dalton, PharmD2*, Hairong Xu, MD, PhD2*, Marcelo Pasquini, MD, MS11 and Partow Kebriaei, MD13

1Division of Hematology, The Ohio State University Wexner Medical Center, Columbus, OH
2Kite, a Gilead Company, Santa Monica, CA
3Memorial Sloan Kettering Cancer Center, New York, NY
4Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
5Thomas Jefferson University, Philadelphia, PA
6Hematology/HCT, City of Hope National Medical Center, Duarte, CA
7Baylor College of Medicine, Center for Cell and Gene Therapy, Houston, TX
8Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
9Department of Hematology & Medical Oncology, Oregon Health and Science University, Portland, OR
10University of Kansas Medical Center, Westwood, KS
11Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI
12Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee, WI
13Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

5:15 PM

Gregory W Roloff, MD1, Ibrahim Aldoss, MD2, Noam E. Kopmar, MD3, Chenyu Lin, MD4, Simone E. Dekker, MD, PhD5, Vishal K Gupta, MD6, Nikeshan Jeyakumar, MD7*, Timothy E O'Connor, MD8, Amy Zhang, PhD9*, Katharine Miller, PhD, MPH9*, Kaitlyn C Dykes, MD10*, Mohamed Ahmed11, Hector Zambrano12*, Danielle Bradshaw, MD13*, Santiago Mercadal, MD14*, Marc Schwartz, MD15*, Sean Tracy, MD, PhD16, Bhagirathbhai Dholaria, MBBS17, Michal Kubiak, MD18, Akash Mukherjee, MD19*, Navneet Majhail, MD, MS, FASTCT20, Minoo Battiwalla, MD21, Luke Mountjoy, DO22, Shahbaz A. Malik, MD23, John Mathews, MD24*, Paul Shaughnessy, MD25, Aaron C. Logan, MD, PhD26, Abdullah Ladha, MD27*, George Yaghmour, MD27, Anjali S. Advani, MD28, Maryann Stefan28*, Caitlin Guzowski, MBA29*, Rasmus T. Hoeg, MD30*, Talal Hilal, MD31, Jozal Moore, MD32, Kristen M. O'Dwyer, MD32, Stephanie B. Tsai, MD, MS8, Joshua Sasine, MD11, Melhem M. Solh, MD29, Catherine J. Lee, MD33, Vamsi K. Kota, MD18, Divya Koura, MD10, Muthu Veeraputhiran, MD19*, Betsy Blunk12*, Jessica T. Leonard, MD34, Veronika Bachanova, MD, PhD35, Wendy Stock, MD1, Ahmed Galal, MD4, Vinod Pullarkat, MD2, Ryan D Cassaday, MD3, Bijal D. Shah, MD36, Rawan Faramand, MD36 and Lori S. Muffly, MD9

1University of Chicago, Chicago, IL
2City of Hope, Duarte, CA
3University of Washington, Seattle, WA
4Duke University School of Medicine, Durham, NC
5Department of Hematology & Medical Oncology, Oregon Health & Science University, Portland, OR
6University of California Los Angeles, Los Angeles, CA
7Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Palo Alto, CA
8Loyola University, Maywood, IL
9Stanford University School of Medicine, Stanford, CA
10University of California San Diego, La Jolla, CA
11Cedars-Sinai Medical Center, Los Angeles, CA
12Sarah Cannon Research Institute, Nashville, TN
13Georgia Cancer Center, Augusta University Medical Center, Augusta, GA
14University of Utah, Salt Lake City, UT
15Division of Hematology, University of Colorado, Aurora, CO
16Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis
17Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN
18Georgia Cancer Center, Augusta University, Augusta, GA
19University of Arkansas for Medical Sciences, Little Rock, AR
20Sarah Cannon Transplant and Cellular Therapy Network, Nashville, TN
21Sarah Cannon Transplant and Cellular Therapy Program at TriStar Centennial Medical Center, Nashville, TN
22Colorado Blood Cancer Institute and Sarah Cannon Cancer Institute at Presbyterian/St Luke’s Medical Center, Denver, CO
23St. David's South Austin Medical Center, Austin, TX
24Sarah Cannon and Texas Oncology Transplant and Cellular Therapy Program at Medical City Dallas, Dallas, TX
25Sarah Cannon Transplant and Cellular Therapy Program at Methodist Hospital, San Antonio, TX
26Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA
27Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA
28Cleveland Clinic Foundation, Cleveland, OH
29Northside Hospital Cancer Institute, Atlanta, GA
30Department of Internal Medicine, Division of Cellular Therapy, Bone Marrow Transplantation and Malignant Hematology, University of California Davis, Sacramento, CA
31Mayo Clinic, Phoenix, AZ
32University of Rochester, Rochester, NY
33Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
34Oregon Health & Science University, Portland, OR
35Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
36Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL

5:30 PM

Anna Ossami Saidy1*, Stephan Fuhrmann, MD2*, Christophe Peczynski, MSc3*, Ariane Boumendil4*, Eva Michel5*, Jacques-Emmanuel Galimard6*, Hervé Finel7*, Michael Daskalakis, MD8*, Urban Novak, MD9*, David Beauvais, MD10*, Peter Vandenberghe, MD, PhD11, Nicolaus Kröger12*, Ron Ram, MD13, Jürgen Finke, MD14, Matthias Stelljes, MD15, Gerald G. Wulf, MD16*, Wolfgang Andreas Bethge, MD17*, Malte von Bonin, MD18*, Gesine Bug, MD19*, Andrea Kuhnl20*, Jakob Passweg Sr.21*, Friedrich Stoelzel22, Bastian von Tresckow, MD23, Anna Maria Sureda Balari, MD, PhD24, Peter Dreger, MD25, Norbert Schmitz, MD26* and Bertram Glass, MD, PhD27*

1Helios Klinikum Berlin Buch, Berlin, Germany
2Praxis für Hämatologie und Onkologie Berlin Mitte, Berlin, DEU
3EBMT Paris study office / CEREST-TC, Hôpital Saint Antoine, Sorbonne University, Paris, France
4EBMT Lymphoma Working Party, Paris Office, Paris, FRA
5EBMT Paris Study Office Paris France, Paris, France
6EBMT ALWP Statistical Unit, Saint Antoine Hospital, Sorbonne University, Paris, Paris, France
7European Society for Blood and Marrow Transplantation, Paris, France
8University Hospital Bern, Inselspital, Bern, Switzerland
9Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
10CHU Lille, Infinite U1286, INSERM, Lille, FRA
11University Hospital Gasthuisberg, Leuven, Belgium
12Universitätsklinikum Hamburg-Eppendorf, Hamburg, Hamburg, AL, DEU
13BMT Unit, Tel Aviv (Sourasky) Medical Center, Tel Aviv, Israel
14Department of Medicine, Hematology-Oncology, University of Freiburg, Freiburg, Germany
15University of Muenster, Muenster, Germany
16Universitaetsklinikum Goettingen, Goettingen, Germany
17Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany
18Department of Internal Medicine I, University Hospital, TU Dresden, Dresden, Germany
19Klinik fuer Innere Medzin III, Ulm, Germany
20King’s College Hospital NHS Foundation Trust, London, United Kingdom
21University Hospital | Basel, Basel, Switzerland
22Department of Internal Medicine II (Hematology/Oncology), University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany
23Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital of Essen, University of Duisburg-Essen, Essen, Germany
24Institut Catala D'Oncologia, Barcelona, Spain
25University of Heidelberg, Heidelberg, Germany
26University Hospital Münster, Münster, DEU
27Klinik für Hämatologie und Zelltherapie, Helios Klinik Berlin-Buch, Berlin, Germany

5:45 PM

Jay Y. Spiegel, MD, FRCPC1, Michael D. Jain, MD, PhD2, Loretta J. Nastoupil, MD3, John Tamaresis, PhD4*, Armin Ghobadi, MD5, Yi Lin, MD, PhD6, Lazaros J. Lekakis7*, Patrick M. Reagan, MD8, Olalekan O. Oluwole, MBBS9, Joseph P McGuirk, DO10, Abhinav Deol, MD11*, Kathleen Dorritie, MD12, Alison R Sehgal, MD12, Andre Goy, MD13, Brian T. Hill, MD14, Charalambos Andreadis, MD15, Javier L. Munoz16, Matthew L. Ulrickson, MD17, Jason Westin, MD18, Julio C. Chavez, MD19, Dilan A Patel20*, Miriam T. Jacobs, MD21*, Radhika Bansal, MBBS6*, N. Nora Bennani, MD22, Vivek Patel, MD9, Aaron P. Rapoport, MD23, Julie M. Vose, MD, MBA24, David B. Miklos, MD, PhD25, Sattva S. Neelapu, MD26, Frederick L. Locke, MD2, Matthew A. Lunning, DO, FACP27* and Saurabh Dahiya25*

1Miller School of Medicine, University of Miami, Miami, FL
2Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
3MD Anderson Cancer Center, Houston, TX
4Department of Biomedical Data Science, Stanford University, Stanford, CA
5Division of Oncology, Washington University School of Medicine, Saint Louis, MO
6Mayo Clinic Cancer Center, Rochester, MN
7Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL
8Wilmot Cancer Institute, University of Rochester Medical Center, Fairport, NY
9Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN
10University of Kansas Medical Center, Westwood, KS
11Karmanos Cancer Institute/ Department of Oncology, Wayne State University, Detroit, MI
12UPMC Hillman Cancer Center, Pittsburgh, PA
13Lymphoma Division, John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ
14Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
15Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, CA
16Department of Hematology, Mayo Clinic, Phoenix, AZ
17Banner MD Anderson Cancer Center, Gilbert, AZ
18Department of Lymphoma and Myeloma, The University of Texas M D Anderson Cancer Center, Houston, TX
19Moffitt Cancer Center, Tampa, FL
20Washington University School of Medicine, Saint Louis, MO
21Medstar Georgetown University Hospital, Washington, DC
22Division of Hematology, Mayo Clinic, Rochester, MN
23University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
24Fred and Pamela Buffett Cancer Center/Division of Hematology and Oncology/Department of Internal Medicine, Univeristy of Nebraska, Omaha, NE
25Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Palo Alto, CA
26Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
27Fred and Pamela Buffett Cancer Center/Division of Hematology and Oncology/Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE

*signifies non-member of ASH